Hot Features

Registration Strip Icon for monitor ブラジル証券取引所、NASDAQ、NYSE、AMEX、LSEなどの主要取引所からの複数のリアルタイム株価を監視します。

BOLT Bolt Biotherapeutics Inc

0.0005 (0.07%)
2024年6月21日 - 終了
名称 銘柄コード 市場 種別
Bolt Biotherapeutics Inc BOLT NASDAQ 普通株式
  前日比 前日比 % 現在値 時刻
0.0005 0.07% 0.7355 07:00:02
始値 安値 高値 終値 前日終値
0.74 0.7301 0.75 0.7355 0.735
この銘柄の詳細情報 »


日付 時間 ソース タイトル
2024/6/1507:54EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/6/1507:45EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/6/1502:15EDGAR2Form 8-K - Current report
2024/5/2102:22EDGAR2Form DEFA14A - Additional definitive proxy soliciting..
2024/5/1606:43EDGAR2Form 3 - Initial statement of beneficial ownership of..
2024/5/1505:14EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/5/1505:06EDGAR2Form 8-K - Current report
2024/5/1505:05GLOBEBolt Biotherapeutics Reports First Quarter 2024 Results,..
2024/3/2205:05GLOBEBolt Biotherapeutics Reports Fourth Quarter and Full-Year..
2024/3/0703:29EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/3/0703:27EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/2/2721:00GLOBEBolt Biotherapeutics to Present at the TD Cowen 44th Annual..
2024/2/1311:41EDGAR2Form SC 13D/A - General statement of acquisition of..
2024/2/0703:09EDGAR2Form 5 - Annual statement of changes in beneficial ownership..
2023/12/2121:30GLOBEPacira Appoints Frank D. Lee as Chief Executive Officer
2023/12/1403:40EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2023/12/0521:00GLOBEBolt Biotherapeutics Enrolls First Patient in Phase 2..
2023/11/1006:10EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2023/11/1006:08EDGAR2Form 8-K - Current report
2023/11/1006:05GLOBEBolt Biotherapeutics Reports Third Quarter 2023 Financial..
2023/11/0721:00GLOBEBolt Biotherapeutics to Present at Stifel 2023 Healthcare..
2023/10/2323:30GLOBEBolt Biotherapeutics Presents Updated Clinical Data from..
2023/10/1820:00GLOBEBolt Biotherapeutics to Present Data at the Society for..
2023/10/1720:00GLOBEBolt Biotherapeutics Announces First Patient Dosed in Phase..
2023/10/1620:00GLOBEBolt Biotherapeutics to Present New Clinical Data from..
2023/9/2820:00GLOBEBolt Biotherapeutics Receives Orphan Drug Designation for..
2023/9/1221:05GLOBEBolt Biotherapeutics Announces Issuance of U.S. Patent..
2023/9/0605:15GLOBEBolt Biotherapeutics to Participate in September Investor..
2023/8/0805:10GLOBEBolt Biotherapeutics Reports Second Quarter 2023 Financial..
2023/8/0805:08EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2023/8/0805:06EDGAR2Form 8-K - Current report
2023/8/0320:30GLOBEBolt Biotherapeutics Initiates Phase 2 Clinical Studies of..
2023/8/0106:27GLOBEBolt Biotherapeutics to Present at BTIG Virtual..


Delayed Upgrade Clock